Drug Type Small molecule drug |
Synonyms PHOX-430 |
Target |
Action inhibitors |
Mechanism GnT-V inhibitors(alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Advanced Malignant Solid Neoplasm | Phase 1 | France | 18 Jul 2022 | |
Advanced Malignant Solid Neoplasm | Phase 1 | Italy | 18 Jul 2022 | |
Bone metastases | Phase 1 | France | 18 Jul 2022 | |
Bone metastases | Phase 1 | Italy | 18 Jul 2022 | |
Glioblastoma Multiforme | Phase 1 | France | 18 Jul 2022 | |
Glioblastoma Multiforme | Phase 1 | Italy | 18 Jul 2022 | |
Liver metastases | Phase 1 | France | 18 Jul 2022 | |
Liver metastases | Phase 1 | Italy | 18 Jul 2022 |